Patients Taking AMD-Treatment Beovu May Be At Risk for Vision Loss
Patients suffering from wet age-related macular degeneration (AMD) who have been treated with the drug Beovu (brolucizumab) may be at an increased risk for another type of vision loss. Though the drug is designed to treat and prevent further vision loss, recent research has suggested…